High materiality8/10
Amylyx price target raised to $40, named a Best Idea at Guggenheim
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises AMLX target to $40; current price $17; price change +$4.59 since signal. Best Idea designation; strong upside potential.
- Target: $40; Posted price: $17; Change: +$4.59
- Analyst firm: Guggenheim
Key facts
- 01
Target: $40
- 02
Posted price: $17
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.